Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ANTIVENINS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 325 records · Page 18Linked to original sources

Pit viper snakebite in the United States.

Pit viper snakebite is a relatively uncommon medical emergency which must be adequately diagnosed and treated to minimize local tissue destruction and systemic complications and to prevent death. Severity is highly variable and may range from minimal local pain and swelling to marked pain, edema, tissue necrosis, hemorrhage, shock, and death within one hour. By far, the most common complication is local tissue destruction often resulting in loss of function. Pit viper venom is extremely complex, containing factors which directly destroy muscle, blood vessels, and renal tissues. Other components anticoagulate blood and cause hypotension, local edema, and pain. Neurotoxicity is unusual, but respiratory paralysis may follow Mojave rattlesnake bites. Proper first aid consists of a proximal mildly constricting tourniquet, superficial incision at fang marks, and constant suction. Medical management consists of early intravenous antivenin in adequate dosage, after hypersensitivity testing. Other measures are largely supportive. The early use of corticosteroids is controversial. Cryotherapy is to be avoided. Fasciotomy may be necessary when edema is severe and impairs arterial perfusion. Promising developments include immunization trials against pit viper venom as well as studies on the antivenom activity of rattlesnake plasma.

Adrenal Cortex Hormones↗

Bites of venomous reptiles.

Bites by venomous reptiles are statistically of minor importance in North America, especially as regards medically significant envenomations. However, they may assume a greater relative incidence in warmer regions and always manage to generate public and professional interest wherever they occur. Unproved and potentially hazardous first-aid and institutional therapies must be subjected to scrutiny in the future. Current research in the area of more specific and less reactive antivenin products is encouraging, and it appears that a consensus approach to the care of the bitten patient is emerging. Physicians are encouraged to consult with regional poison control centers in the care of these patients unless they are well experienced in this unique and complicated area.

Animals↗

Rattlesnake bites in Northern California.

In a series of 59 cases of rattlesnake bites at two major northern California hospitals, no deaths occurred, no amputations or fasciotomies were required and only one patient had tissue necrosis requiring a graft. Because patients are being seen in major medical facilities earlier, envenomation is encountered in earlier stages. Less specific national standards of treatment, therefore, should receive less emphasis than treatment based on the virulence of the snakes in the particular geographic region. Initial doses of antivenin given intravenously should be based on the degree of envenomation, with additional titration done for worsening symptoms.

Adolescent↗

Black widow spider bite.

Latrodectus mactans has now invaded towns and cities. The spider's venom is a neurotoxin that causes little local reaction but produces pain and spasm in large skeletal muscle groups within 30 minutes to three hours after the bite. Severe envenomation may result in respiratory failure and coma. First aid is of no value. Muscle relaxants are useful in treatment, as is calcium gluconate. Antivenin is indicated for high-risk victims, such as those with hypertension and persons younger than 16 or older than 60 years of age.

Antivenins↗

Snakebite and snake venom ophthalmia.

Snakebite is not necessarily snake envenomation. Of about 2,500 known species of snakes, only about 40 are regarded as being dangerous. A snake will not go out of its way to attack a person and even in defense, snakes bite humans usually to dissuade and not to kill.Early surgical excision of the bitten area is regarded as a most important aspect in the management of a poisonous snakebite, and because of the side effects of horse serum, cautious use of antivenin is advised only in cases of severe systemic poisoning.When a snake spits into the eyes, prompt treatment is indicated to prevent future blindness.

Adolescent↗

When a snake bites.

Primary care physicians may be required to treat snake-bitten patients and must differentiate between venomous and nonvenomous snakes. The chief distinguishing characteristics of venomous snakes are fangs and a single row of subcaudal anal plates. The physiologic effects of snake venom are on the cardiovascular, hematologic, and neurovascular systems. The snake-bitten patient first needs supportive treatment and stabilization. Then, the physician must establish whether envenomation has occurred, grade it, and monitor edema around the bite. Local treatment, broad-spectrum antibiotics, and tetanus prophylaxis should be used for all envenomation grades. The decision to administer antivenin therapy should be made on clinical grounds and the envenomation grade. Its use, however, can lead to anaphylaxis and anticomplement reactions.

Anti-Bacterial Agents↗

Insufficient stocking of poisoning antidotes in hospital pharmacies.

OBJECTIVE: To determine whether antidotes for poisoning and overdose are available in hospitals that provide emergency department care. DESIGN: Written survey of hospital pharmacy directors, each of whom reported the amount currently in stock of 8 different antidotes: antivenin (Crotalidae) polyvalent, cyanide kit, deferoxamine mesylate, digoxin immune Fab, ethanol, naloxone hydrochloride, pralidoxime chloride, and pyridoxine hydrochloride. PARTICIPANTS: Pharmacy directors of all hospitals with emergency departments in Colorado, Montana, and Nevada. MAIN OUTCOME MEASURES: Proportions of hospitals with insufficient stocking of each antidote, defined as complete lack of the antidote or an amount inadequate to initiate treatment of 1 seriously poisoned 70-kg patient. RESULTS: Questionnaires were mailed to 137 hospital pharmacy directors and 108 (79%) responded. Only 1 (0.9%) of the 108 hospitals stocked all 8 antidotes in adequate amounts. The rate of insufficient stocking for individual antidotes ranged from 2% (for naloxone) to 98% (for digoxin immune Fab). In a multiple regression analysis, smaller hospital size and lack of a formal review of antidote stocking were independent predictors of the number of antidotes stocked insufficiently. CONCLUSIONS: Insufficient stocking of antidotes is a widespread problem in Colorado, Montana, and Nevada. Although these states are served by a certified regional poison center, potentially lifesaving antidotes are frequently not available when and where they might be needed to treat a single poisoned patient.

Analysis of Variance↗

Rattlesnake envenomations: unusual case presentations.

Rattlesnake envenomations are common in some areas of the United States. Although fatal rattlesnake envenomations are rare and usually preventable, morbidity may be significant. Patients may present with localized edema, hypotension, coagulopathy, or thrombocytopenia. Patients with progressive swelling or severe coagulopathy are typically treated with Crotalidae polyvalent antivenin. We present a series of 4 patients with unusual complications of rattlesnake envenomation to illustrate the wide spectrum of disease that may be encountered. These case presentations include anaphylaxis to rattlesnake venom, an acute airway emergency, progressive and marked edema with a large pleural fluid collection, and death.

Adult↗

Differential biodistribution of native and 2 kGy 60Co irradiated crotoxin in tissues of CBA/J mice.

Crotalus durissus envenomation is treated using antivenins produced in horses. During production, animals have problems, sometimes followed by death, due to the high toxicity of the main toxin, crotoxin. Several methods tested to detoxify this toxin often resulted in decreased immunogenicity. Gamma irradiation has proved to be a successful method for crotoxin detoxification without loss of immunogenicity. We have studied the biodistribution of 2 kGy 60Co irradiated crotoxin (iCTX) in mouse tissues. We used both 125I-labeled iCTX or its detection by a specific immunohistochemistry assay (IHA). Both approaches showed similar early excretion of toxins by the kidneys. Higher iCTX uptake was seen in spleen and liver, which are rich in immune responder cells. In contrast to previous reports concerning native crotoxin (nCTX), we failed to detect iCTX in the neuromuscular junction, but both toxins were found on the kidney tubular cell surface, with rapid excretion that was more intense for iCTX. Kupffer cells and splenocyte macrophages presented IHA staining, as shown by the increased uptake of 125I toxin by these organs. No staining was observed in the brain, lung or heart, which also showed very low 125I counts. Allied to reduced toxicity, irradiation induced early endocytosis of crotoxin by phagocytic cells, improving antigen processing.

Animals↗

Effect of diethylenetriaminepentaacetic acid and procaine on hemorrhage induced by rattlesnake venom.

Nineteen compounds and seven combinations of compounds were tested for their ability to neutralize the hemorrhagic activity of Crotalus atrox venom in vitro and in vivo. Two compounds and four combinations were effective in reducing hemorrhage in an in vivo test in which the venom was injected before injection of compounds. DTPA plus procaine HCl was the most effective combination and reduced hemorrhage when injected 1, 5, or 15 minutes after injection of venom. DTPA-procaine reduced hemorrhage induced by injection of C. atrox venom into dogs as well as mice. DTPA in combination with procaine did not reduce myonecrosis or lethality resulting from injection of venom into mice, but it could be used in conjunction with antivenin to treat local tissue damage resulting from rattlesnake venom poisoning.

Animals↗

Inactivation of West-Nile virus during peptic cleavage of horse plasma IgG.

Peptic cleavage of horse plasma IgG is a common procedure for the preparation of F(ab)(2) products for human use, such as antivenin and antitoxin. The removal of the Fc fragment from the IgG molecule by enzymatic cleavage at low pH, ensures fewer side-effects of the F(ab)(2) product for passive immunotherapy compared with the whole IgG molecule. Since the starting material may be contaminated by zoonotic horse viruses, it is necessary to demonstrate the removal or inactivation of possible viral contaminants. Guidelines for performing such studies were published by the Commission for Plasma-Derived Medical Products (CPMP), and updated by the Committee for Proprietary Medical Products. It is recommended that viral clearance studies be performed on scaled down production processes that have been identified as possibly contributing to virus clearance and spiking of a model virus to the starting material. The model virus should be non-pathogenic but closely related to the potential infective virus. By quantifying the amount of virus in the product before and after the production process, the amount of virus cleared can be determined. Log(10) reductions of the order of 4 logs or more, and a biphasic inactivation curve (fast initial phase followed by a slower phase), are indicative of a clearance effect with a particular test virus under investigation.

Animals↗

Immunotherapy in the poisoned patient. Overview of present applications and future trends.

Immunotherapy for reversal of toxicity due to poisons and drugs is not new. However, refinements in antibody isolation and purification as well as the advancement of hybridoma technology and recombinant DNA biotechnology has led to a new generation of immunotherapeutic and diagnostic agents. The advent of monoclonal antibody technology in 1975 heralded the new age of immunopharmacology and immunotoxicology. Monoclonal antibodies designed for a specific antigen resolved the problem of polyclonality and cross-reactivity of traditional antibodies. Along with the production and isolation of active antibody fragments from both polyclonal and human monoclonal sources, as well as the ability to tailor-make chimeric antibodies by recombinant biotechnology, the development of novel immunotherapeutic agents has taken place. Two immunotherapeutic modalities, digoxin-specific antibody fragments (Fab) and snake antivenin, have been available for the clinician's armamentarium for years. Along the same lines of anti-digoxin Fab development, application of newer antibody isolation technology has led to a purified IgG(T) antibody for snake venom poisoning which is still in the developmental stages. Potential future developments in immunotherapeutics must overcome the clinical problems of immunogenicity and adverse reactions to the antibodies. Human monoclonal sources, active antibody fragments, and chimeric antibodies from transfectomas are all potential resolutions to these problems.

Antibodies↗

Acute arthropod envenomation. Incidence, clinical features and management.

Black widow spider (Latrodectus mactans) envenomation is found throughout both the temperate and tropical latitudes, and is one of the leading causes of death from arthropod envenomations worldwide. The venom is highly neurotoxic, affecting the presynaptic motor endplate to allow massive noradrenaline (norepinephrine) and acetylcholine release into synapses causing excessive stimulation and fatigue of the motor end plate and muscle. Clinically, patients develop a bite site lesion and pain, abdominal pain and tenderness, and lower extremity pain and weakness within minutes to hours of envenomation. Symptoms progress over several hours, then subside over 2 to 3 days. The recommended treatment of 'common' envenomation is calcium gluconate 10% intravenously, titrated to relief of symptoms; antivenin, although effective, may cause hypersensitivity and serum sickness reactions, and should be restricted to life-threatening envenomations only. Brown recluse spider (Loxosceles reclusa) envenomations are seen in the Americas and in Europe, and are endemic to the south and central United States. The venom contains at least 8 enzymes, consisting of various lysins (facilitating venom spread) and sphingomyelinase D, which causes cell membrane injury and lysis, thrombosis, local ischaemia, and chemotaxis. Local envenomations begin as pain and itching that progresses to vesiculation with violaceous necrosis and surrounding erythema, and ultimately ulcer formation. Systemic envenomations may be life threatening, and present with fever, constitutional symptoms, petechial eruptions, thrombocytopenia, and haemolysis with haemoglobinuric renal failure. Treatment of local envenomations is conservative (local wound care, cryotherapy, elevation, tetanus prophylaxis, and close follow-up); systemic envenomation requires supportive care and treatment of arising complications, corticosteroids to stabilise red blood cell membranes, and support of renal function. Dapsone 100mg daily has emerged as a promising therapeutic agent in both animal studies and clinical trials. Over 650 species of scorpions are known to cause envenomation (mostly in children under 10 years); they are endemic mostly in arid and tropical areas. Different venoms and clinical presentations are seen across the different species. Most commonly, an inflammatory local reaction occurs with envenomation, which is treated with wound debridement and cleaning, tetanus prophylaxis, and antihistamines. Occasionally the venom is allergenic, and the resultant allergic reaction is treated in a standard fashion.(ABSTRACT TRUNCATED AT 400 WORDS)

Animals↗

Antibiotic prophylaxis for pit viper envenomation: prospective, controlled trial.

The efficacy of prophylactic antibiotics for preventing infectious complications at the site of pit viper envenomation has not been well studied. We undertook a prospective, controlled trial of antibiotic treatment versus no antibiotic treatment among 114 victims of crotalid envenomation in Ecuador's Amazon rain forest. A group of 59 patients received intravenous gentamicin and chloramphenicol, and 55 patients did not. All other aspects of care were identical. There were no statistically significant differences between antibiotic-treated and untreated patients with regard to demographics, delay in treatment, clinical and laboratory evidence of severity of envenomation, or use of antivenin. Nine abscesses occurred, six in the antibiotic-treated group and three in the untreated group. The results of this study did not show any statistically significant differences in outcome in terms of the number of abscesses that occurred between antibiotic-treated and untreated patients. Based on this lack of differences, routine use of prophylactic antibiotics for prevention of infectious complications of crotalid envenomation cannot be recommended.

Abscess↗

Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia.

This work deals with a clinical and epidemiological study of the scorpion envenomation in Tunisia, from 717 scorpion stings recorded during a year at the Sfax Hospital with a mortality rate of 0.35%, all the patients died being less 15 years old. The serotherapy with a specific antivenin made in the Institut Pasteur of Tunis is the main element of the therapeutics.

Adolescent↗

Envenomation by the Mojave rattlesnake (Crotalus scutulatus scutulatus) in southern Arizona, U.S.A.

Fifteen cases of envenomation by the Mojave rattlesnake (Crotalus scutulatus scutulatus) are reviewed. Systemic effects were observed in eight patients, consisting of early hypotension (3), decreased plasma fibrinogen (3) and platelets (2), elevated fibrinolytic split products (3) and eyelid ptosis (1). Local venom effects were most common and included swelling (15), ecchymosis (10), bleb formation (6) and necrosis (3). Effects upon neuromuscular transmission were neither common nor a clinical problem. Treatment consisted of i.v. crystalloid solution (15) and antivenin (12).

Adult↗